Targeted treatments of psoriasis vulgaris recommended by guidelines

摘要：

Introduction Psoriasis is a common chronic recurrent inflammatory skin disease with most common clinical form of chronic plaque type (90％).For moderate-to-severe psoriasis vulgaris patients,who were inadequately responding to other synthetic therapies,targeting therapeutic drugs may have unexpected effects.And with the deepening understanding of pathogenesis,the targeted therapy for psoriasis is increasingly diverse and accurate.Biologic agents can block T cell activation,antagonise T cell secretion of tumor necrosis factor alpha (TNF-α),interleukin (IL)-17,IL-23,and other cytokines,and then effectively block the immune inflammatory response.

所属期刊栏目：1

资助基金：CAMS Innovation Fund for Medical Sciences2016-I2M-1-002;the National Natural Science Foundation of China81472872

在线出版日期：2018-10-29（万方平台首次上网日期，不代表论文的发表时间）

页数：共10页

页码：141-150